26 Mar 2013, BioSpectrum Bureau , BioSpectrum
Singapore: Pharmaceutical Product Development (PPD) has appointed Mr Jay Dixon as senior vice president, global quality and compliance. Mr Dixon's expertise will enhance PPD's ability to deliver industry-leading drug development services and high-quality data across the full spectrum of the R&D life cycle.
"In today's changing regulatory landscape, quality and compliance programs must continually evolve to meet and exceed international guidelines," said Mr David Simmons, PPD chairman and chief executive officer.
"Jay's combination of leadership skills and biopharmaceutical and contract research organization experience will enable PPD to continue fulfilling its commitment to providing superior quality and compliance solutions for clients," he added.
"Biopharmaceutical companies depend on PPD's quality and compliance programs to help protect the integrity of their research and development programs," Mr Dixon said.
"By ensuring adherence to protocols and international regulatory guidelines, we are helping our clients bring needed therapies to market while protecting the welfare and rights of clinical trial participants," Mr Dixon added.